SCHEMBL30612516

CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	APLNR	P35414	2/20	0.55

▸	CALCR	P30988	3/20	0.54

▸	GLP1R	P43220	4/20	0.52

▸	GCGR	P47871	3/20	0.52

▸	GIPR	P48546	1/20	0.52

▸	VIPR1	P32241	2/20	0.52

▸	TFPI	P10646	1/20	0.52

▸	SCTR	P47872	1/20	0.51

▸	VIPR2	P41587	2/20	0.51

▸	CRHR1	P34998	1/20	0.51

▸	CRHR2	Q13324	1/20	0.51

▸	PTH1R	Q03431	1/20	0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31672250	0.91	APLNR (0.59)	APLNRGLP1RGCGRGIPRVIPR1
SCHEMBL31672269	0.88	APLNR (0.58)	APLNRCALCRGLP1RGCGRTFPI
SCHEMBL31127551	0.87	CALCR (0.67)	CALCRGLP1RGCGRVIPR1TFPI
SCHEMBL30512566	0.87	NPY4R (0.59)	APLNR
SCHEMBL31672253	0.86	APLNR (0.54)	APLNRGLP1RGCGRGIPRPTH1R
SCHEMBL30176478	0.86	PTH1R (0.62)	CALCRGLP1RVIPR1TFPIVIPR2
SCHEMBL30435635	0.86	GLP1R (0.62)	GLP1RGCGRVIPR1SCTRVIPR2
SCHEMBL29707438	0.85	TFPI (0.62)	GLP1RGCGRGIPRVIPR1TFPI
SCHEMBL30910839	0.85	VIPR1 (0.65)	GLP1RGCGRVIPR1TFPISCTR
SCHEMBL30567714	0.85	CALCR (0.64)	CALCRGLP1RGCGRGIPRVIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-11759509-B2	WT1 antigen peptide conjugate vaccine	Sumitomo Pharma Co., Ltd. (JP)	2023-09-19	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-11759509-B2	WT1 antigen peptide conjugate vaccine	MICA, HLA-DRB1, HLA-B	APLNR 1914/4885CALCR 1765/4885GLP1R 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.